

NCT02526823 Raw comparison:

Summary:
CHIA has 17 criteria while your personal folder has 19 criteria
Total found criteria: 17/17
Total not Found: 0/17
Total Extra: 2
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Primary B-NHL PTCL (ALK+ anaplastic large cell     │ Primary B-NHL PTCL (ALK+ anaplastic large cell     │
│ lymphoma and NK(natural killer cell )/T cell       │ lymphoma and NK(natural killer cell )/T cell       │
│ lymphoma were excluded) or HL patients confirmed   │ lymphoma were excluded) or HL patients confirmed   │
│ by histopathology                                  │ by histopathology                                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Ages =18 years old < 80 years old                  │ Ages ≥18 years old \< 80 years old                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ ECOG (Eastern Cooperative Oncology Group)score 0-2 │ ECOG (Eastern Cooperative Oncology Group）score    │
│                                                    │ 0-2                                                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ At least one measurable lesion                     │ At least one measurable lesion                     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Expected survival time=3 months                    │ Expected survival time≥3 months                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Liver function transaminase=2 5× upper limit of    │ Liver function transaminase≤2 5× upper limit of    │
│ normal value bilirubin=1 5×upper limit of normal   │ normal value，bilirubin≤1 5×upper limit of normal  │
│ value                                              │ value                                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Renal function serum creatinine is 44-133 mmol/L   │ Renal function serum creatinine is 44-133 mmol/L   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Routine blood test WBC=3 0×109/L Neutrophils=1     │ Routine blood test：WBC≥3 0×109/L，Neutrophils≥1   │
│ 5×109/L Hb=100g/L Platelet=80×109/L LVEF=50%       │ 5×109/L，Hb≥100g/L，Platelet≥80×109/L； LVEF≥50%   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ New York Heart Association (NYHA) heart function   │ New York Heart Association (NYHA) heart function   │
│ classification is I-II grade                       │ classification is I-II grade                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ signed informed consent                            │ signed informed consent                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with severe complications or severe       │ Patients with severe complications or severe       │
│ infection                                          │ infection                                          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Invasion of central nervous system                 │ Invasion of central nervous system                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with severe heart disease history         │ Patients with severe heart disease history         │
│ including ventricular tachycardia (VT) atrial      │ including ventricular tachycardia (VT) atrial      │
│ fibrillation (AF) heart block myocardial           │ fibrillation (AF) heart block myocardial           │
│ infarction (MI) congestive heart failure (CHF)     │ infarction (MI) congestive heart failure (CHF)     │
│ coronary heart disease patients needed therapy     │ coronary heart disease patients needed therapy     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ patients with severe allergic constitution or      │ patients with severe allergic constitution or      │
│ those who are allergic to or intolerant of drug    │ those who are allergic to or intolerant of drug    │
│ composition in chemotherapy regimens with other    │ composition in chemotherapy regimens with other    │
│ malignant tumors in the past 5 years               │ malignant tumors in the past 5 years               │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ patients received doxorubicin therapy total        │ patients received doxorubicin therapy total        │
│ cumulative dose of adriamycin was more than 300    │ cumulative dose of adriamycin was more than 300    │
│ mg/m2 total cumulative dose of epirubicin was more │ mg/m2 total cumulative dose of epirubicin was more │
│ than 450 mg/m2                                     │ than 450 mg/m2                                     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients participate in other clinical studies     │ Patients participate in other clinical studies     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Other patients who are not suitable for the study  │ Other patients who are not suitable for the study  │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒═══════════════════════════════════╕
│ Extra Personal Criteria           │
╞═══════════════════════════════════╡
│ Must have maximum age of 80 Years │
├───────────────────────────────────┤
│ Must have minimum age of 18 Years │
╘═══════════════════════════════════╛